Natural product-based therapeutics targeting chemotherapeutic resistance in mammary cancers: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, inhibits mammary cancer recurrence through suppression of the SPSB1–c-MET pathway, 13/July/2014, 5.40 am

Anti-metastatic therapy: Metformin, the widely used drug in the treatment of NIDDM, inhibits invasion and metastasis via down regulation of ubiquitin specific peptidase 25, 13/July/2014, 5.36 am
July 13, 2014
Insights into the treatment of Neurodegenerative disorders: Curcumin, the major component of turmeric, increases the expression of neuroprotective proteins Parkin and DJ-1 via up regulation of its target gene, 13/July/2014, 5.44 am
July 13, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan PhD

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Natural product-based therapeutics targeting chemotherapeutic  resistance in mammary cancers: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent,  inhibits mammary cancer recurrence through suppression of the SPSB1–c-MET pathway, 13/July/2014, 5.40 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.